Blood component therapy in obstetrics.
Hemorrhage is the leading cause of intensive care unit admission and one of the leading causes of death in the obstetric population. This emphasizes the importance of a working knowledge of the indications for and complications associated with blood product replacement in obstetric practice. This article provides current information regarding preparation for and administration of blood products, discusses alternatives to banked blood in the obstetric population, and introduces pharmacological strategies for treatment of hemorrhage.
Fuller
Andrea J
AJ
Department of Anesthesiology, University of Colorado Denver Health Sciences Center, 4200 E. 9th Avenue, B-113, Denver, CO 80262, USA. andisamf@msn.com
Bucklin
Brenda
B
D016913:Blood Component Transfusion / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D006473:Postpartum Hemorrhage / Q000628:therapy*; D011247:Pregnancy